stock

Lilly(Eli) & Co (LLY)

0
December 2nd, 2020

Share

Stay up to date

Eli Lilly and Company is an American pharmaceutical company headquartered in Indianapolis, Indiana, with offices in 18 countries. Its products are sold in approximately 125 countries. The company was founded in 1876 by, and named after, Col. Eli Lilly, a pharmaceutical chemist and veteran of the American Civil War. Lilly's notable achievements include being the first company to mass-produce the polio vaccine developed by Jonas Salk, and insulin. It was one of the first pharmaceutical companies to produce human insulin using recombinant DNA including Humulin , Humalog , and the first approved biosimilar insulin product in the US, Basaglar .

Financial Statements

Key Info

  • Industry: Pharmaceutical Preparation Manufacturing
  • Sector: Manufacturing
  • CEO Name: David Ricks

Key Statistics

  • Stock Price: $145.56
  • Dividend Yield: 2.0%
  • Market Capitalization: $139,240,017,405
  • Shares Outstanding: 956,581,598
  • Number of Employees: 35,815
  • Trailing 12-Month EPS: $6.11
  • Trailing 12-Month DPS: $2.94
  • Payout Ratio: 48.1%

Important Dates

  • Next Earnings Date:
  • Next Ex-Dividend Date: 2020-11-12

Price Trends

  • Current Stock Price: $145.56
  • 52-week high: $167.45
  • 52-week low: $116.34
  • 200-day moving average: $150.04
  • 50-day moving average: $141.32

Performance

  • 1-Month Price Return: 12.1%
  • 3-Month Price Return: -0.7%
  • 6-Month Price Return: -3.6%
  • 1-Year Price Return: 26.5%
  • 2-Year Price Return: 28.0%
  • 5-Year Price Return: 89.6%

Visit the Passiv Stock Directory

Data provided by IEX Cloud

December 2nd, 2020